Pilot or pivotal ? [General Sta­tis­tics]

posted by ElMaestro  – Belgium?, 2018-06-27 14:48 (882 d 06:54 ago) – Posting: # 18979
Views: 8,688

Hi Ohlbe,

» Sure, when you only have one test formulation. But when you hesitate between two ? Would you directly go for a pivotal where both test formulations would be compared to the reference, and then file whichever one passes ?

This is purely hypothetical for me. As far as I recall, I have not ever faced such a situation where two test formulations targeting the same authority were heads-on compared in a pivotal trial. I have faced it numerous times in pilot trials, but here the choice of formulation rarely is based on the CI but just on the observed GMR.

If I were in a situation, hypothetically, where I had one pivotal trial with two passing T formulations against a single, and I only needed one approval, then I am not sure what I would base my choice on. It could be cost of goods, or a risk-based assessment of the manufacturing bottlenecks for the two T formulations. Not sure, I have a feeling this would not be science-driven but Guy-in-Armani-suit-driven.

I could be wrong, but...

Best regards,
ElMaestro

No, of course you do not need to audit your CRO if it was inspected in 1968 by the agency of Crabongostan.

Complete thread:

Activity
 Admin contact
21,210 posts in 4,426 threads, 1,481 registered users;
online 18 (0 registered, 18 guests [including 15 identified bots]).
Forum time: Wednesday 20:42 CET (Europe/Vienna)

You can’t fix by analysis
what you bungled by design.    Richard J. Light, Judith D. Singer, John B. Willett

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5